Cart
sales@molnova.com
Beta-boswellic acid
CAS No. 631-69-6
Beta-boswellic acid( —— )
Catalog No. M22800 CAS No. 631-69-6
Beta-boswellic acid and its derivatives (the major constituents of Boswellin) have anti-carcinogenic, anti-tumor, and anti-hyperlipidemic activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 164 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 224 | In Stock |
|
| 25MG | 383 | In Stock |
|
| 50MG | 545 | In Stock |
|
| 100MG | 771 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBeta-boswellic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionBeta-boswellic acid and its derivatives (the major constituents of Boswellin) have anti-carcinogenic, anti-tumor, and anti-hyperlipidemic activities.
-
DescriptionBeta-boswellic acid and its derivatives (the major constituents of Boswellin) have anti-carcinogenic, anti-tumor, and anti-hyperlipidemic activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
Recptor5-Lipoxygenase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number631-69-6
-
Formula Weight456.7
-
Molecular FormulaC30H48O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (218.96 mM)
-
SMILESC[C@]12[C@@](CC=C3[C@]2(CC[C@]4(C)[C@@]3([H])[C@H]([C@H](C)CC4)C)C)([H])[C@@]5([C@@]([C@](C)([C@H](O)CC5)C(O)=O)([H])CC1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study).Neurol Sci. 2010 Jun;31(3):315-20.
molnova catalog
related products
-
NNK
NNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.
-
S-2474
S-2474, an inhibitor of COX-2 and 5-lipoxygenase, has anti-inflammatory and neuroprotective activities and inhibits Abeta (25 - 35) and Abeta (1 - 40) induced cell death.
-
Utreloxastat
Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis .
